Sitemap

American Heart Association retracts a scientific study on the use of e-cigarettes

More...

Maxence Liagre, New CEO of MPC Properties

Mr Liagre is a leading global real...

The Highlights Of The New Mercedes-Maybach S-Class

The Mercedes-Maybach S-Class is particularly suitable for...

Foreign Investors Council Presented The White Book 2020

The Foreign Investors Council presented the White...

Michael Shannon Appointed General Manager Of Hyatt Regency Belgrade

Mr. Michael Shannon has been selected as...

News

G20 Summit: G20 Leaders United To Address Major Global Pandemic And Economic Challenges

President of the European Commission, Ursula von der Leyen, and President of the European Council, Charles Michel, represented the EU at...

SSCC promotes the Serbian ICT market to Swiss companies

SSCC promotes the Serbian ICT market to Swiss companies in cooperation with Switzerland Global Enterprise. Switzerland Global Enterprise S-GE...

Government Of Serbia Adopts 2021 Budget Bill

At today's session, the government of the Republic of Serbia adopted the Bill on the Budget of the Republic...

EU Donates Ambulances, Mobile Respirators And Protective Equipment

Twelve new ambulances with modern equipment, decontamination vehicles and protective equipment will be available to the health system in...

Government Passes New Anti-coronavirus Measures

The Serbian government adopted new measures to suppress the epidemic caused by the COVID-19 infectious disease, whose implementation will...

The American Heart Association (AHA) retracted a scientific study where the use of e-cigarettes is directly linked to a risk of heart attack, because the study conclusion is unreliable, as reported in the Association’s journal.

Editors of the specialised journal published a note with the retraction of the study, whose author is Dr. Stanton Glantz, professor of medicine and director of the Center for Tobacco Control Research and Education at University of California San Francisco, with associates, underlining that it is potentially based on misleading results of the study and that key information from the U.S. Population Assessment of Tobacco and Health study.

“There is growing evidence that legally sold and scientifically verified products that do not combust, like e-cigarettes and heated tobacco products, while not risk-free, are a much better alternative to cigarettes for those who would otherwise continue smoking,” as stated in the explanation.

It is added that this evidence is supported by a growing number of independent studies and conclusions of leading expert organizations like the U.S. Food and Drugs Authority, Public Health England and the Royal College of Physicians in Australia.

In recent years, a growing number of governments have been updating older legislation to differentiate the smoke-free category from cigarettes, recognizing their different nature and potential for public health versus smoking. This is the case with the U.S., the U.K., Italy and Portugal, while others, like New Zealand and Greece, have announced steps in this direction.

Another study, by Dr. Auer et al., generated significant coverage that misled the public on the potential risk reduction of a heated tobacco product, IQOS.

This story in the Daily Mail, for instance, reported that “IQOS generates more toxins than originally thought. Philip Morris International, the maker of IQOS, criticized the methodology and conclusions of the study.

The U.S. Food and Drugs Authority in its conclusions on the review of evidence on the product decided not to consider the study because “the data published is not considered adequate for comparing the levels of HPHCs between the IQOS products and combusted cigarettes.”

“There are significant analytical issues in the Auer et al. study, such as lack of testing reference samples, low number of replicates and lack of selectivity on some analytical methods. In comparison, we have not identified specific issues with the applicant’s methods,” concluded Philip Morris International.

The decision of one of the leading scientific publications to retract the study which links the use of e-cigarettes with the myocardial infarctions is also supported by the National Institutes of Health, stating that this act “can help avoid potential harm to a scientific field, wasted resources, lost time and, in some cases, harm to patient populations, if done in a timely manner”.

“This story simply confirms what I have been arguing for a long time – that there is a profound anti-e-cigarette bias among tobacco-control researchers, and this is precisely what caused this fiasco,” said Michael Siegel, a professor of community health sciences at Boston University.

One of the first who called for the retraction of the study, published in June last year, was New York University professor David Abrams, a former head of the National Institute for Health’s Office on behavioural and social science research, with a group of 16 academics, scientists and other public health experts. Abrams is now drafting letters to the National Institutes of Health’s Office of Research Integrity and the University of California San Francisco’s president to request investigations of other Glantz research.

Related Articles

Philip Morris International Invested USD20 mn In The Niš-based Plant Modernisation

Philip Morris International invested USD20 mn in its production facility in Niš this year and thus the company’s overall investments in Serbia reached nearly...

Business sector and individuals in the fight against coronavirus

The list of donations of the business sector, business and sports associations, charities and individuals is getting longer daily, with the donors allocating significant...

Philip Morris Won The “Top Employer” Certificate For The Fifth Year

Philip Morris Serbia has received the “Top Employer“ certificate and thus assumed the position of one of the best employers in Serbia and the...

Aleksandar Jakovljević, Managing Director of Philip Morris

Dedicated to Change

IQOS is currently used by around 12 million consumers in the world, eight million of whom have completely left their cigarettes and made this...

PMI is first multinational company to achieve global EQUAL-SALARY certification

Philip Morris International today achieved an important ‘first’ and a key milestone on its inclusion and diversity journey on the road to creating a...

Philip Morris a reliable partner of the Serbian government

Prime Minister Ana Brnabić visited today the company Philip Morris in Niš, which in September 2003 privatised the largest Serbian tobacco factory DIN, and...

Philip Morris launches a new production system in Niš

Philip Morris International (PMI) has launched a new $3 million production system in its factory in Niš, which completely automates the management of finished...

Jelena Pavlović, President of AmCham, President of BoD, Philip Morris SEE

Stronger Institutions At The Core Of Reform Progress

To move forward with the reform agenda in an effective and sustainable manner, we need to strengthen the competence and efficiency of Serbian institutions....